New Blue Health is a technology and administrative services platform for telehealth intake, care coordination, and educational content related to GLP-1 and peptide care discussions. Medical services are provided by independent licensed medical groups, and New Blue Health is not a medical provider or pharmacy.
Our public content is educational. It is designed to help patients understand treatment categories, risks, evidence limits, pricing context, and operational policies before a clinician conversation. Prescriptions are never automatic or guaranteed.
If treatment is prescribed, medication is prepared by a state-licensed 503A compounding pharmacy based on a valid prescription for the individual patient. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality.
How review and evidence standards work
New Blue pairs patient education with clinician review and explicit evidence framing. Patients can review how content is developed, how evidence is graded, and how updates are handled before starting care.
Operational and disclosure pages
Patients can also review operational and disclosure pages covering compounding, availability, privacy, and refund questions before starting intake.
This page is educational and does not replace individualized medical advice from a licensed clinician.